Capillary Technologies India: Allotment of Equity Shares under Capillary Employees Stock Option Scheme – 2021 ( " ESOP plan 2021 " )
Capillary Technologies India (CAPILLARY) filed a disclosure titled "Allotment of Equity Shares under Capillary Employees Stock Option Scheme – 2021 ( " ESOP plan 2021 " )". The company is valued at about ₹4,090 crore.
What happened
Capillary Technologies India (CAPILLARY) filed a disclosure with the exchanges on 4 November 2026 at 12:44 PM titled "Allotment of Equity Shares under Capillary Employees Stock Option Scheme – 2021 ( " ESOP plan 2021 " )".
Company snapshot
Capillary Technologies India is a small-cap company in the Information Technology sector, with a market value of about ₹4,090 crore.
The stock last traded at ₹513.9, against a 52-week range of ₹438.2–₹799 (35.7% below the high).
Before this filing the shares had moved −8.5% over the month and −5.1% over three months. Average daily turnover over the last 20 sessions was about ₹21.6 crore.
Promoters held 47.23% at the end of Q2 FY27, down 4.22% points from the previous quarter. Foreign institutions owned 2.56% and domestic institutions 21.87%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q3 FY26 | 184 | 8 | 1.05 |
| Q4 FY26 | 191 | 43.4 | 5.47 |
| Q1 FY27 | 257 | -9.6 | -1.2 |
| Q2 FY27 | 271 | 21.9 | 2.75 |
What history shows
BCEIE has no earlier fund raising filing from this company on record since May 2026.
Across 18 similar disclosures by other Information Technology companies, shares moved −0.3% on average the next day and −0.8% over five days; 56% of them rose the next day.
Market-wide, 1,727 fund raising filings with an impact score of 50 or more saw an average next-day move of +0.3%, with 47% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- How the money raised is used and, for equity instruments, the dilution for existing shareholders.
In the news
Recent coverage elsewhere (links open the original publisher):
- [Update] Forensic Audit Finds External Breach Behind €3 Mn Capillary Fraud
- Capillary Technologies forensic audit uncovers €3 million payment-diversion fraud
- SaaS firm Capillary Technologies’ Q2 profit at Rs 21.9 crore, revenue rises 51%
- Capillary Technologies Fraud: KPMG finds impersonation likely behind 3-million-euro loss at Czech unit
- Capillary Technologies IPO GMP Today, Expected Listing Gain & Price Band
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.